WSGR 2022 Mid-Year Technology and Life Sciences IPO Report

Wilson Sonsini Goodrich & Rosati released its 2022 Mid-Year Technology and Life Sciences "Non" IPO Report. Following a record-breaking year for initial public offerings (IPOs) in 2021, the U.S. capital markets screeched to a halt in 2022 with the lowest IPO activity levels seen in decades. This trend was observed across all sectors as increasingly risk-adverse investors have been deterred from growth stories and projections. Instead, many are opting for a “wait-and-see” approach, resulting in IPO levels similar to those seen at the height of the financial crisis in 2009. To read the report, click here.